Acknowledgements We are grateful to B
Continuous monitoring of patient outcomes and post-marketing surveillance will help ensure that these therapies are used safely and effectively
GLP-1 weight loss costs are expected to increase again between approximately 130 percent (low estimate) and nearly 200 percent (high estimate), by the end of the second quarter in fiscal year 2027, according to the departments budget request
For individuals with type 2 diabetes, low blood sugar levels (hypoglycemia) can be a concern when GLP-1 agonists are used in combination with other glucose-lowering medications, such as sulfonylureas or insulin
[DOI] [PMC free article] [PubMed] [Google Scholar] 187.Fukamizu Y., Uchida Y., Shigekawa A., Sato T., Kosaka H., Sakurai T
Common examples include nicotine patches for smoking cessation, hormone patches for hormone replacement therapy, and pain relief patches